|
|
 Acne (1,500)
Addictions (1,500)
Advice (1,500)
Allergies (1,092)
Alternative Medicine (1,500)
Anti Aging (1,500)
Breakup (1,500)
Cancer (1,499)
Dental Care (1,500)
Disabilities (1,500)
Divorce (1,500)
Elderly Care (1,498)
Goal Setting (1,500)
Hair Loss (1,500)
Health and Safety (1,497)
Hearing (1,500)
Law of Attraction (1,499)
Marriage (1,500)
Medicine (1,497)
Meditation (1,499)
Men's Health (1,500)
Mental Health (1,500)
Motivational (1,500)
Nutrition (1,495)
Personal Injury (1,499)
Plastic Surgeries (1,500)
Pregnancy (1,496)
Psychology (1,500)
Public Speaking (1,500)
Quit Smoking (1,500)
Religion (1,499)
Self Help (1,500)
Skin Care (1,500)
Sleep (1,500)
Stress Management (1,500)
Teenagers (1,492)
Time Management (1,500)
Weddings (1,500)
Wellness (1,500)
Women's Health (1,500)
Women's Issues (1,500)
|
AlphaRx, Inc. (ALRX) SWOT Profile is a comprehensive business, functional and strategic analysis of AlphaRx, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
AlphaRX, Inc. (AlphaRX), formerly known as Logic Tech International Inc, is a pharmaceutical company engaged in the research and development of novel therapeutic products. It is focused on the development of innovative medicines and drug delivery platforms. The company uses its proprietary site-specific nano drug delivery technologies for the development of products. Its products address various pharmaceutical markets, including stroke, inflammation and pneumonia.
Key Recent Developments
Mar 29, 2010: AlphaRx Plans To List Subsidiary
Jan 21, 2010: Gaia BioPharma Signs Agreement To Manufacture GAI-122
Dec 17, 2009: AlphaRx Enters Into Contract Manufacturing Agreement For Hepatitis Drug
Scope
- Examines key information about company for business intelligence.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information – business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Note: Some of the elements mentioned above will be included in the profile based on the availability of information.
More Information Please Click:
Or Call Us: 919272852585
Visit Our Blog:
|
|
|
